Chromatic computerized analysis is an early predictor of cardiovascular risk associated to hypercholesterolemia

Revista Espanola de Cardiologia

Volumn 54, Issue 12, 2001, Pages 1417-1425

  Alcalá, Antonio ^a   Morell, Miguel ^a   Rius, Francisca ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Cholesterol; Coronary disease; Diagnosis

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EYE DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUROANATOMY; NEUROLOGIC DISEASE; PREDICTION; SENSITIVITY AND SPECIFICITY; VISUAL CORTEX; CARDIOVASCULAR DISEASE; COLOR VISION; COLOR VISION TEST; COMPUTER ASSISTED DIAGNOSIS; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; TIME;

ADULT; AGED; CARDIOVASCULAR DISEASES; COLOR PERCEPTION; COLOR PERCEPTION TESTS; DIAGNOSIS, COMPUTER-ASSISTED; ENGLISH ABSTRACT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0035542937     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(01)76525-6     Document Type: Article

References (40)

1. Neuropathological criteria for the diagnosis of Alzheimer's disease: Are we really ready yet?
2. Risk factors for cerebral degenerative changes and dementia
3. Neuropathological studies on strains of senescence accelerated mice with age-related deficits in learning and memory
4. Normal human aging: Factors contributing to cerebral atrophy
5. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
6. Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease
7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
8. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
9. Umbral foveal cromático: Una nueva técnica para la exploración de los colores: Nuestra experiencia con las formas subclínicas de esclerosis múltiple
10. Enzymatic determination of total serum cholesterol
11. Quantitative determination of serum tryglicerides by use of enzymes
12. 2
13. Pupillary escape in disease of the retina or the optic nerve
14. Afferente pupillary defects: Pupillary findings associated with defects of the afferent arm of the pupillary light reflex arc
15. Techniques of examination of the fundus periphery
16. Telescopic eyepieces in indirect ophthalmoscopy
17. Vitreous base classification of retinal tears: Cinical aplication
18. A new tonometer-the pressure phosphene tonometer: Clinical comparison with Goldman tonometry
19. Comparison of visual fields defects in the low tension glaucomas with those in the high tension glaucomas
20. The effect of perimetric experience in normal subjects
21. Traumatic lesions of the chiasm
22. Early impairment of foveal magno and parvocellular pathways in juxtachiasmal tumours
23. Comparison of red-green, blue-yellow and achromatic losses in glaucoma
24. Responses to chromatic and luminance contrast in glaucoma: A psychophysical and electrophysiological study
25. Chromatic-Contrast threshold impairment in diabetes
26. Bioactive lipids in excitatory neurotransmission and neural plasticity
27. Role of nitric oxide in retinal cell death
28. Relationship of oxygen radical induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS
29. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/-mice: Isoform-specific effects on neurodegeneration
30. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
31. Anatomical organization of macaque monkey striate visual cortex
32. Serum cholesterol as a prognostic factor after myocardial infarction. The Framingham Study
33. Subclinical atherosclerosis. An objective index of suceptibility and vascular risk
34. Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease: The Scandinavian Simvastatin Survival Study (4S)
35. Likely gains in life expectancy of patients with coronary artery disease treated with HMG-CoA reductase inhibitors as predicted by decision analysis model
36. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects
37. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study
38. Optimum parameters for short-wavelength automated perimetry